The company has two R&D centers in Beijing and Changchun, equipped with advanced laboratories and led by overseas returnee scientists with PhDs. It has a biopharmaceutical, biosimilar and clinical R&D team of more than 150 people, and has built four major innovative technology platforms, covering the entire process from early research to late clinical development. It has successfully developed and launched a variety of key biopharmaceutical intermediates and biological tool enzyme products, and achieved fruitful project results.

Huisheng Biopharm has a biopharmaceutical and chemical drug production base with leading technology and first-class equipment. The production base not only meets domestic GMP standards, but also FDA and EU standards. The biopharmaceutical base is equipped with fermentation and purification equipment for scale-up from pilot to industrial scale, with a designed annual production capacity exceeding 25 million units.

Huisheng’s international team brings extensive global collaboration experience. With professionalism and efficiency, we support the worldwide cooperation of Huisheng’s products and technologies.